COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production

COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production

Abstract Background Dexamethasone is currently administered for Coronavirus disease 2019(COVID-19); however, there are concerns about its effect on specific antibodies’ production. The aim of this study was to evaluate whether specific antibodies were affected by COVID-19 severity and corticosteroid...

Full description

Bibliographic Details
Main Authors: Takato Nakamoto, Noriko Iwamoto, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Satohi Ide, Keiji Nakamura, Hidetoshi Nomoto, Yutaro Akiyama, Tetsuya Suzuki, Yusuke Miyazato, Michiyo Suzuki, Kumiko Suzuki, Moto Kimura, Sho Saito, Satoshi Kutsuna, Norio Ohmagari
Format: Article
Language:English
Published: BMC 2024-10-01
Series:BMC Infectious Diseases
Subjects:
COVID-19
Specific antibody
Corticosteroids
Severity
Online Access:https://doi.org/10.1186/s12879-024-10090-z

Internet

https://doi.org/10.1186/s12879-024-10090-z

Similar Items